About US
Contact us
-
Merck receives FDA approval for Victrelis to treat chronic hepatitis CThe U.S. Food and Drug Administration today approved Victrelis (boceprevir) to treat certain adults with chronic hepatitis C. Victrelis is used for patients who still have some liver function, and who2011/5/16
-
Linguamatics introduces I2E award-winning software for pharmaceutical companiesLinguamatics, the leader in NLP-based enterprise text mining for life sciences and other markets, announces the latest release of its award-winning software platform, I2E. Version 3.2 reflects Linguam2011/5/13
-
Health Canada approves EMEND IV formulation to prevent chemotherapy-induced nausea, vomitingToday Merck announced that Health Canada has approved the new intravenous formulation of EMEND® IV (fosaprepitant dimeglumine). Used in combination with a 5-HT3 antagonist class of antiemetics and2011/5/13
-
FDA Fast Tracks Bayer's Cancer DrugThe US Food and Drug Administration has granted fast-track designation for Bayer Healthcare's regorafenib for the treatment of gastrointestinal stromal tumours. The fast-track process is designed t2011/5/12
-
Drug Regulators Accused of Protecting Profits Rather Than PatientsDrug regulators are protecting the profits of drug companies rather than the lives and welfare of patients by withholding unpublished trial data, researchers have argued. Writing in an article publ2011/5/12
-
Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritisThe Laboratory Department for Probiotics Research at the Juntendo University Graduate School of Medicine (NAGATA Satoru, YAMASHIRO Yuichiro et al.) studied supplementation of probiotic fermented milk2011/5/11
-
Scientists discover how HIV drugs can kill pathogenic parasitesDrugs used to treat HIV may form templates for lifesaving drugs targeted at malaria and other parasitic diseases, according to a new study from Cardiff University. While scientists know that some2011/5/11
-
Ideal psychotropic drug may cause physical dependenceA report in the current issue of Psychotherapy and Psychosomatics by a group of European investigators headed by Fabrizio Schifano (UK) has explored the potential for dependence of pregabalin using pa2011/5/10
-
Technical Requirements for the Study of Changing Propellent for Marketed Inhaled Aerosols issuedAccording to the National Program for Ozone Depleting Substances (ODS) Phase-out in China of the State Council, the State Food and Drug Administration recently formulated and issued the Technical Requ2011/5/10
-
Coumadin tablet lot recalledBristol-Myers Squibb issues recall for one lot of 5-mg warfarin tablets due to possible superpotency. Bristol-Myers Squibb has initiated a voluntary recall of one lot of 1,000-count bottles of Coum2011/5/9